Search research articles
Contact Us
Filters
Showing results (1-10 of 128) with videos related to
Page
of 13
Sort By:
Human Reproduction Update
|
October 24, 2008
The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis
Caroline F Wright, Hilary Burton
Frontiers in Genetics
|
August 19, 2022
Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts
Rebecca Kingdom, Caroline F Wright
European Journal of Human Genetics : EJHG
|
April 21, 2026
Revisiting penetrance in an era of genomic screening
Leigh Jackson, Caroline F Wright
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 3, 2022
Estimating diagnostic noise in panel-based genomic analysis
Robin N Beaumont, Caroline F Wright
Genome Medicine
|
October 7, 2025
Reply to: 'Predicted loss-of-function variants before Met584 in ARID1B in population cohorts likely reflect reduced penetrance and should be reported diagnostically'
Caroline F Wright, Robin N Beaumont
Developmental Medicine and Child Neurology
|
June 18, 2011
The Deciphering Developmental Disorders (DDD) study
Helen V Firth, Caroline F Wright,
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 11, 2010
Size of the direct-to-consumer genomic testing market
Caroline F Wright, Shelley Gregory-Jones
BMJ (Clinical Research Ed.)
|
July 8, 2009
Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing
Caroline F Wright, Lyn S Chitty
Epidemiology, Biostatistics and Public Health
|
March 15, 2016
Conceptual issues for screening in the genomic era - time for an update?
Caroline F Wright, Ron L Zimmern
Journal of Community Genetics
|
December 13, 2019
Expanded universal carrier screening and its implementation within a publicly funded healthcare service
Charlotte A Rowe, Caroline F Wright
Page
of 13
Search research articles
Search
Showing results (1-10 of 128) with videos related to
Sort By:
Page
of 13
Human Reproduction Update
|
October 24, 2008
The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis
Caroline F Wright, Hilary Burton
Frontiers in Genetics
|
August 19, 2022
Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts
Rebecca Kingdom, Caroline F Wright
European Journal of Human Genetics : EJHG
|
April 21, 2026
Revisiting penetrance in an era of genomic screening
Leigh Jackson, Caroline F Wright
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 3, 2022
Estimating diagnostic noise in panel-based genomic analysis
Robin N Beaumont, Caroline F Wright
Genome Medicine
|
October 7, 2025
Reply to: 'Predicted loss-of-function variants before Met584 in ARID1B in population cohorts likely reflect reduced penetrance and should be reported diagnostically'
Caroline F Wright, Robin N Beaumont
Developmental Medicine and Child Neurology
|
June 18, 2011
The Deciphering Developmental Disorders (DDD) study
Helen V Firth, Caroline F Wright,
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 11, 2010
Size of the direct-to-consumer genomic testing market
Caroline F Wright, Shelley Gregory-Jones
BMJ (Clinical Research Ed.)
|
July 8, 2009
Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing
Caroline F Wright, Lyn S Chitty
Epidemiology, Biostatistics and Public Health
|
March 15, 2016
Conceptual issues for screening in the genomic era - time for an update?
Caroline F Wright, Ron L Zimmern
Journal of Community Genetics
|
December 13, 2019
Expanded universal carrier screening and its implementation within a publicly funded healthcare service
Charlotte A Rowe, Caroline F Wright
Page
of 13